In our study, baseline serum NGAL levels had the potential to predict MACE independent of age, sex, hypertension, diabetes, smoking status, serum creatinine levels and serum LDL-C levels in stable patients with CAD after a PCI. The gene discussed is LCN2; the disease is diabetes mellitus.